Quantifying the economic benefits of prevention in a healthcare setting with severe financial constraints: the case of hypertension control

References

• WHO. A global brief on hypertension. Geneva: World Health Organization; 2013
   Google Scholar
• MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765–74
   PubMed Web of Science ®Google Scholar
• Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003;289:2534–44
   PubMed Web of Science ®Google Scholar
• Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003;34:2741–8
   PubMed Web of Science ®Google Scholar
• He J, Whelton PK, Appel LJ, et al. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000;35:544–9
   PubMed Web of Science ®Google Scholar
• Freis ED. Salt, volume and the prevention of hypertension. Circulation 1976;53:589–95
   PubMed Web of Science ®Google Scholar
• Haapanen N, Miillunpalo S, Vuori I, et al. Association of leisure time physical activity with the risk of coronary heart disease, hypertension and diabetes in middle-aged men and women. Int J Epidemiol 1997;26:739–47
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (US) Committee on Preventing the Global Epidemic of Cardiovascular Disease. Meeting the challenges in developing countries. In: Fuster V, Kelly BB, eds. Promoting cardiovascular health in the developing world: a critical challenge to achieve global health. Washington, DC: National Academies Press (US); 2010:125–45
   Google Scholar
• A report by the World Economic Forum and the Harvard School of Public Health, September 2011. The Global Economic Burden of Non-communicable Diseases. Available from: http://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf [last accessed 20 Sep 2014]
   Google Scholar
• Gaziano TA, Bitton A, Anand S, Weinstein MC. The global cost of nonoptimal blood pressure. J Hypertens 2009;27:1472–7
   PubMed Web of Science ®Google Scholar
• Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014;129:399–410
   PubMed Web of Science ®Google Scholar
• Leal J, Luengo-Fernandez R, Gray A, et al. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006;27:1610–19
   PubMed Web of Science ®Google Scholar
• Lloyd A, Schmieder C, Marchant N. Financial and health costs of uncontrolled blood pressure in the United Kingdom. Pharmacoeconomics 2003;21:33–41
   PubMed Web of Science ®Google Scholar
• Danaei G, Finucane MM, Lin JK, et al; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Pressure). National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 54 million participants. Lancet 2011;377:568–77
   PubMed Web of Science ®Google Scholar
• Athanasakis K, Souliotis K, Tountas Y, et al. A cost-utility analysis of hypertension treatment in Greece: assessing the impact of age, sex and smoking status, on outcomes. J Hypertens 2012;30:227–34
   PubMed Web of Science ®Google Scholar
• Efstratopoulos AD, Voyaki SM, Baltas AA, et al. Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study. Am J Hypertens 2006;19:53–60
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159–219
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486–97
   PubMed Web of Science ®Google Scholar
• D’Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 1994;25:40–3
   PubMed Web of Science ®Google Scholar
• Peeters A, Mamum AA, Willekens F, Bonneux L. A cardiovascular lifehistory. A life course analysis of the original Framingham Heart Study cohort. Eur Heart J 2002;23:458–66
   PubMed Web of Science ®Google Scholar
• Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003
   PubMed Web of Science ®Google Scholar
• Panagiotakos DB, Fitzgerald AP, Pitsavos C, et al. Statistical modeling of 10-year fatal cardiovascular disease risk in Greece: the HellenicSCORE (a Calibration of the ESC Score Project). Hellenic J Cardiol 2007;48:55–63
   PubMedGoogle Scholar
• Psaltopoulou T, Orfanos P, Naska A, et al. Prevalence, awareness, treatment and control of hypertension in a general population sample of 26 913 adults in the Greece EPIC study. Int J Epidemiol 2004;33:1345–52
   PubMed Web of Science ®Google Scholar
• Filippidis FT, Vardavas CI, Loukopoulou A, et al. Prevalence and determinants of tobacco use among adults in Greece: 4 year trends. Eur J Public Health 2013;23:772–6
   PubMed Web of Science ®Google Scholar
• National Statistical Authority of Greece. Available from: www.statistics.gr (last accessed 28 Oct 2013)
   Google Scholar
• Hellenic Ministry of Health, KEN-DRGs. Available from: http://www.moh.gov.gr/articles/health/domes-kai-draseis-gia-thn-ygeia/articles/health/domes-kai-draseis-gia-thn-ygeia/articles/health/domes-kai-draseis-gia-thn-ygeia/articles/ken-eswteriko/1079-nea-lista-ken-apo-1-3-2012-kostos-mdn (last accessed 27 Oct 2013)
   Google Scholar
• Gioldasis G, Talelli P, Chroni E, et al. In-hospital direct cost of acute ischemic and hemorrhagic stroke in Greece. Acta Neurol Scand 2008;118:268–74
   PubMed Web of Science ®Google Scholar
• Drummond M, O’Brien B, Stoddart G, Torrance G. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005
   Google Scholar
• Organisation for Economic Co-operation and Development (OECD). Available from: http://stats.oecd.org (last accessed 21 Sept 2014)
   Google Scholar
• Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994;50:272–98
   PubMed Web of Science ®Google Scholar
• Hansson L. The benefits of lowering elevated blood pressure: a critical review of studies of cardiovascular morbidity and mortality in hypertension. J Hypertens 1996;14:537–44
   PubMed Web of Science ®Google Scholar
• He FJ, MacGregor GA. Cost of poor blood pressure control in the UK: 62 000 unnecessary deaths per year. J Hum Hypertens 2003;17:455–7
   PubMed Web of Science ®Google Scholar
• Hansson L, Lloyd A, Anderson P, Kopp Z. Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe. Blood Press 2002;11:35–45
   PubMed Web of Science ®Google Scholar
• Gaziano TA, Bitton A, Anand S, Weinstein MC. The global cost of non optimal blood pressure. J Hypertens 2009;27:1472–7
   PubMed Web of Science ®Google Scholar
• Luengo-Fernandez R, Leal J, Gray A, et al. Cost of cardiovascular diseases in the United Kingdom. Heart 2006;92:1384–9
   PubMed Web of Science ®Google Scholar
• Liu JL, Maniadakis N, Gray A, Rayner M. The economic burden of coronary heart disease in the UK. Heart 2002;88:597–603
   PubMed Web of Science ®Google Scholar
• Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000;21:365–70
   PubMed Web of Science ®Google Scholar